Des Moines Water Works has launched a program to replace about 1,000 residential lead water service lines in the city of Des Moines, focusing the first phase of the effort on homes in a portion of ...

Add Yahoo as a preferred source to see more of our stories on Google. Image via White House Days before President Donald Trump's White House ballroom faces a final vote, architects are warning that ...

On March 23, the Maryland House passed HB 1067 by a 91 to 42 vote, thereby taking an important step toward protecting people and non-target wildlife from plumbism — lead poisoning from bullet ...

Maintaining phase consistency across RF cable assemblies is essential for multichannel, high-frequency systems. This article outlines a practical approach to defining and controlling phase reference ...

Myanmar voters returned to the polls in military-controlled areas on Sunday for the second phase of an election organized by the ruling junta, a process rejected by several western governments and ...

Actual sized mock up of the lead cooled small modular reactor from Newcleo at an exhibition in Venice.Pininfarina/ Facebook French firm Newcleo has submitted the design of its lead-cooled small ...

President Donald Trump has tapped a new architect to help plan his $300 million White House ballroom wing, assigning the former lead designer to a consultant role in the high-profile and controversial ...

Alan Dye, Apple's Vice President of Human Interface Design, has been poached by Meta, Bloomberg reports. The designer played a pivotal role in the look and feel of Apple's products since Jony Ive left ...

igus is innovating in motion control with a focus on materials science and precision engineering. The company offers flexible, reliable solutions suitable for both high-volume and custom applications.

Enhanced susceptibilities in ferroelectrics often arise near phase boundaries between competing ground states. While chemically-induced phase boundaries have enabled ultrahigh electrical and ...

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedema Phase IIb trial to ...